Tag:
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- Don't miss an Exclusive Executive Breakfast at BIO 2012!June 19, 2012 — Boston, MA
Press Releases
- Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement
- AVEO Initiates Phase 1 Study of AV-203, an ERBB3 Inhibitory Antibody, in Advanced Solid Tumors
- Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100
- InterMune to Divest Actimmune® (Interferon Gamma-1b)
- France Biotech presents the results of its tenth annual "Life Science Panorama 2011" survey, conducted in partnership with Ernst & Young
- More Press Releases
Featured Jobs
-
Quality Assurance Specialist Job
Yoh - Lexington, MA, USA -
Senior Manager, Clinical Data Management
TESARO - Waltham, MA -
Director, Shared Services Americas Lead Job
Celgene Corporation - Berkeley Heights, NJ, US -
Neurosciences Knowledge Group Lead
Merck - Rahway, NJ - Kenilworth, NJ - West Point, PA - Boston, MA -
Senior Scientist Analytical Chemistry - Permanent Job
Yoh - Mountain View, CA, USA
